POS-2026-3020 : Primary Care Eligibility Analysis – SGLT2I and DOAC
Some new medicines can help people with conditions like diabetes, heart problems, and blood clots to stay healthier and avoid getting seriously ill. However, data suggests that access can vary depending on where people live, so some people who need them might not be getting them.
This project will use NHS data to work out how many people in each area should be getting these medicines according to recommendations from NICE, the National Institute for Health and Care Excellence. NICE is an independent organisation that carefully reviews medical evidence and provides guidance to the NHS on which treatments work best and offer good value. When NICE recommends a medicine, it means there is strong evidence it can help patients and the NHS is expected to make it available to those who need it.
By comparing who should be getting these medicines with who actually is, NHS teams will be able to see where access is lacking and take steps to improve it. This helps ensure that everyone gets fair access to effective treatments, meaning people across the country can stay healthier, avoid unnecessary hospital visits, and receive the same high standard of care wherever they live.
- Study leads: Dominick Moran, Daisy Nash
- Organisation: NICE (National Institute for Health and Care Excellence)
- Project type: Service evaluation
- Start date: 16 November 2026
- View project progress, open code and outputs